CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Efficacy and safety of liraglutide 3.0 mg in adult overweight and obese weight loss responders without diabetes: results of the randomised, double-blind, placebo-controlled 56-week SCALE Obesity and Prediabetes trial
DOI 10.1055/s-0035-1556574
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP O'Neil, K Fujioka, R Violante Ortiz, B Claudius, C Jensen, A Astrup, J Kienhöfer, A Hamann
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe08/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
The randomized, double-blind, placebo-controlled trial SCALE Obesity and Prediabetes (NCT01272219) evaluated the efficacy and safety of liraglutide 3.0 mg in weight management. Overweight/obese individuals (BMI ≥27 kg/m2 with ≥1 comorbidity or ≥30 kg/m2) without T2D (age 45 years, 79% female, body weight 106 kg, BMI 38 kg/m2) were randomized 2:1 to liraglutide 3.0 mg (n = 2487) or placebo (n = 1244) plus diet and ex…
Zitieren
Zitierempfehlung
P O'Neil, K Fujioka, R Violante Ortiz, B Claudius, C Jensen, A Astrup, J Kienhöfer, A Hamann (2015) Efficacy and safety of liraglutide 3.0 mg in adult overweight and obese weight loss responders without diabetes: results of the randomised, double-blind, placebo-controlled 56-week SCALE Obesity and Prediabetes trial. Diabetologie und Stoffwechsel (08). https://doi.org/10.1055/s-0035-1556574
Mit CareLit weiterarbeiten